Joint Formulary & PAD

Bumetanide - Nocturnal polyuria

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Bumetanide
Indication :
Nocturnal polyuria
Group Name :
Keywords :
loop diuretics, LUTS
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

The PCN recommends the following medicines as treatment options for the management of nocturnal polyuria in men and has assigned the following traffic light status to each treatment option as follows -

Furosemide – BLUE (no information sheet)
Bumetanide – BLUE (no information sheet)

If the treatment options above are initiated by specialists in secondary care, the specialist should prescribe at least one month of treatment prior to transfer of care.

Note: This is an off-label use

Other Indications

Below are listed other indications that Bumetanide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Nocturnal polyuria.